China · Delayed Price · Currency is CNY Huaxia Eye Hospital Group Statistics
Total Valuation
SHE:301267 has a market cap or net worth of CNY 12.45 billion. The enterprise value is 9.68 billion.
| Market Cap | 12.45B |
| Enterprise Value | 9.68B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
SHE:301267 has 832.47 million shares outstanding. The number of shares has increased by 0.84% in one year.
| Current Share Class | 832.47M |
| Shares Outstanding | 832.47M |
| Shares Change (YoY) | +0.84% |
| Shares Change (QoQ) | +7.93% |
| Owned by Insiders (%) | 61.55% |
| Owned by Institutions (%) | 4.50% |
| Float | 163.13M |
Valuation Ratios
The trailing PE ratio is 26.61 and the forward PE ratio is 23.75.
| PE Ratio | 26.61 |
| Forward PE | 23.75 |
| PS Ratio | 2.96 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | 17.11 |
| P/OCF Ratio | 13.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.26, with an EV/FCF ratio of 13.30.
| EV / Earnings | 20.45 |
| EV / Sales | 2.30 |
| EV / EBITDA | 10.26 |
| EV / EBIT | 15.52 |
| EV / FCF | 13.30 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.69 |
| Quick Ratio | 3.42 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 1.48 |
| Interest Coverage | 13.29 |
Financial Efficiency
Return on equity (ROE) is 7.85% and return on invested capital (ROIC) is 17.00%.
| Return on Equity (ROE) | 7.85% |
| Return on Assets (ROA) | 4.87% |
| Return on Invested Capital (ROIC) | 17.00% |
| Return on Capital Employed (ROCE) | 9.51% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | 513,258 |
| Profits Per Employee | 57,701 |
| Employee Count | 8,200 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 12.21 |
Taxes
In the past 12 months, SHE:301267 has paid 158.87 million in taxes.
| Income Tax | 158.87M |
| Effective Tax Rate | 25.24% |
Stock Price Statistics
The stock price has decreased by -22.97% in the last 52 weeks. The beta is 0.47, so SHE:301267's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -22.97% |
| 50-Day Moving Average | 15.22 |
| 200-Day Moving Average | 16.73 |
| Relative Strength Index (RSI) | 49.85 |
| Average Volume (20 Days) | 4,184,875 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301267 had revenue of CNY 4.21 billion and earned 473.15 million in profits. Earnings per share was 0.56.
| Revenue | 4.21B |
| Gross Profit | 1.80B |
| Operating Income | 623.51M |
| Pretax Income | 629.33M |
| Net Income | 473.15M |
| EBITDA | 787.15M |
| EBIT | 623.51M |
| Earnings Per Share (EPS) | 0.56 |
Balance Sheet
The company has 4.04 billion in cash and 1.08 billion in debt, with a net cash position of 2.96 billion or 3.56 per share.
| Cash & Cash Equivalents | 4.04B |
| Total Debt | 1.08B |
| Net Cash | 2.96B |
| Net Cash Per Share | 3.56 |
| Equity (Book Value) | 5.78B |
| Book Value Per Share | 6.72 |
| Working Capital | 3.48B |
Cash Flow
In the last 12 months, operating cash flow was 930.30 million and capital expenditures -202.58 million, giving a free cash flow of 727.72 million.
| Operating Cash Flow | 930.30M |
| Capital Expenditures | -202.58M |
| Depreciation & Amortization | 163.64M |
| Net Borrowing | -444.69M |
| Free Cash Flow | 727.72M |
| FCF Per Share | 0.87 |
Margins
Gross margin is 42.76%, with operating and profit margins of 14.81% and 11.24%.
| Gross Margin | 42.76% |
| Operating Margin | 14.81% |
| Pretax Margin | 14.95% |
| Profit Margin | 11.24% |
| EBITDA Margin | 18.70% |
| EBIT Margin | 14.81% |
| FCF Margin | 17.29% |
Dividends & Yields
This stock pays an annual dividend of 0.26, which amounts to a dividend yield of 1.74%.
| Dividend Per Share | 0.26 |
| Dividend Yield | 1.74% |
| Dividend Growth (YoY) | 18.18% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 47.06% |
| FCF Payout Ratio | 29.74% |
| Buyback Yield | -0.84% |
| Shareholder Yield | 0.90% |
| Earnings Yield | 3.76% |
| FCF Yield | 5.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:301267 is 24.19, which is 61.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24.19 |
| Price Target Difference | 61.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 8.26% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 11, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 11, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:301267 has an Altman Z-Score of 6.07 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.07 |
| Piotroski F-Score | 5 |